SCHEMBL18974999

SCHEMBL18974999

O=C(O)CCCN1C(=O)C(=O)c2ccccc21

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 6/20 0.67
▸ BCHE P06276 2/20 0.67
▸ ALDH1A1 P00352 5/20 0.66
▸ ALDH2 P05091 4/20 0.66
▸ ALDH3A1 P30838 4/20 0.66
▸ PKM P14618 1/20 0.66
▸ CDC25A P30304 1/20 0.61
▸ PARK7 Q99497 1/20 0.60
▸ TGM2 P21980 1/20 0.57
▸ MEN1 O00255 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ CHRM1 P11229 1/20 0.55
▸ APEX1 P27695 1/20 0.53
▸ TP53 P04637 1/20 0.52
▸ PARP1 P09874 1/20 0.51
▸ MAOA P21397 1/20 0.50
▸ MAOB P27338 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1519990 0.90 CES1 (0.71) CES1BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL25119569 0.85 CES1 (0.85) CES1BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL25119255 0.83 CES1 (0.84) CES1BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL4624469 0.82 CES1 (0.73) CES1BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL29459522 0.82 KMT2A (0.73) ALDH1A1MEN1KMT2A
SCHEMBL877279 0.82 KMT2A (0.73) ALDH1A1MEN1KMT2A
SCHEMBL4627352 0.81 CES1 (0.51) CES1BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL19924204 0.81 CES1 (1.00) CES1BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL19020196 0.80 CDC25A (0.54) CDC25AMEN1KMT2AAPEX1
SCHEMBL18974294 0.80 ALDH1A1 (0.62) CES1BCHEALDH1A1ALDH2ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback